Star Health & Allied Insurance Ltd Faces Bearish Momentum Amid Technical Downgrade

Technical Trend Shift and Price Movement

Star Health’s share price closed at ₹446.75 on 10 Mar 2026, down 2.69% from the previous close of ₹459.10. The intraday range was between ₹433.90 and ₹454.05, indicating heightened volatility. Over the past week, the stock declined by 3.66%, slightly underperforming the Sensex’s 3.33% drop. On a one-month basis, Star Health’s return was -3.47%, outperforming the Sensex’s sharper 7.73% decline, while year-to-date the stock is down 1.81% compared to the Sensex’s 8.98% fall.

Despite these short-term setbacks, the stock has delivered a robust 21.9% return over the last year, significantly outpacing the Sensex’s 4.35% gain. However, the three-year return of -22.91% contrasts starkly with the Sensex’s 29.7% rise, highlighting mixed longer-term performance.

MACD and Momentum Indicators Signal Bearishness

The Moving Average Convergence Divergence (MACD) indicator remains a critical gauge of momentum. On the weekly chart, the MACD is firmly bearish, reflecting sustained downward momentum. The monthly MACD, while mildly bearish, suggests that the longer-term trend is weakening but not yet decisively negative. This divergence between weekly and monthly MACD readings indicates that short-term selling pressure is more pronounced, while the longer-term trend may still hold some resilience.

The KST (Know Sure Thing) indicator adds nuance, showing a weekly bearish signal but a mildly bullish monthly reading. This suggests that while immediate momentum is negative, there could be underlying strength that might stabilise the stock if conditions improve.

RSI and Bollinger Bands Confirm Pressure

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no clear signal, hovering in neutral territory. This implies the stock is neither oversold nor overbought, leaving room for further downside or a potential reversal depending on market catalysts.

Bollinger Bands, however, are signalling bearishness on both weekly and monthly charts. The stock price is trending towards the lower band, indicating increased selling pressure and volatility. This technical setup often precedes further declines unless a strong reversal catalyst emerges.

Moving Averages and Dow Theory Analysis

Daily moving averages are firmly bearish, with the stock trading below key averages such as the 50-day and 200-day moving averages. This confirms the prevailing downtrend in the short term. The Dow Theory assessment aligns with this view, showing a mildly bearish weekly trend but a mildly bullish monthly trend, reinforcing the mixed signals from other indicators.

On Balance Volume (OBV) shows no clear trend on weekly or monthly charts, suggesting that volume is not confirming either buying or selling pressure decisively. This lack of volume confirmation may limit the strength of any immediate price moves.

Mojo Score and Rating Downgrade

MarketsMOJO has downgraded Star Health & Allied Insurance from a 'Hold' to a 'Sell' rating as of 20 Feb 2026, reflecting the deteriorating technical outlook. The current Mojo Score stands at 30.0, a low figure signalling weak overall momentum and quality metrics. The Market Cap Grade is 3, indicating a mid-tier market capitalisation within the insurance sector.

This downgrade is consistent with the technical trend shifting from mildly bearish to outright bearish, signalling caution for investors. The downgrade also reflects the stock’s inability to sustain gains above its 52-week high of ₹533.90, with the current price of ₹446.75 closer to the 52-week low of ₹330.05.

Sector and Industry Context

Operating within the insurance sector, Star Health faces sector-wide headwinds including regulatory pressures and competitive challenges. While the broader Sensex has experienced sharper declines over recent months, Star Health’s relative outperformance year-to-date and over one year suggests some resilience. However, the negative technical signals imply that this resilience may be tested further in the near term.

Investors should weigh these technical signals alongside fundamental factors such as underwriting performance, claims ratios, and regulatory developments before making portfolio decisions.

Investor Takeaway and Outlook

Star Health & Allied Insurance’s current technical profile suggests caution. The convergence of bearish MACD, Bollinger Bands, and moving averages indicates that the stock is under selling pressure and may face further downside in the short term. The neutral RSI and lack of volume confirmation imply that any recovery attempts could be tentative.

Longer-term investors should consider the stock’s strong one-year return and sector fundamentals but remain vigilant for signs of trend reversal. The mildly bullish monthly KST and Dow Theory readings offer some hope for stabilisation, but these are outweighed by the dominant weekly bearish signals.

Given the downgrade to a 'Sell' rating and the low Mojo Score, investors may prefer to explore alternative insurance stocks or sectors with stronger technical momentum and more favourable risk-reward profiles.

Comparative Performance Summary

Over the past year, Star Health’s 21.9% return has comfortably outpaced the Sensex’s 4.35%, highlighting its potential for growth despite recent setbacks. However, the three-year performance of -22.91% versus the Sensex’s 29.7% gain underscores the stock’s volatility and cyclical challenges. This mixed performance profile reinforces the importance of technical analysis in timing entry and exit points.

Conclusion

In summary, Star Health & Allied Insurance Company Ltd is currently navigating a bearish technical phase, with multiple indicators signalling downward momentum. The downgrade to a 'Sell' rating by MarketsMOJO and a low Mojo Score of 30.0 reflect this cautious stance. Investors should monitor key technical levels and sector developments closely, balancing short-term risks against longer-term growth potential.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →